EFFECTS OF ANTENATAL ANTIHELMINTHIC TREATMENT ON PREGNANCY OUTCOMES IN UITH ILORIN: A RANDOMISED CONTROLLED TRIAL.
Not Applicable
Completed
- Conditions
- HelminthiasisPregnancy and Childbirth
- Registration Number
- PACTR202008475715326
- Lead Sponsor
- Dr Afusat Olabinjo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 176
Inclusion Criteria
•All consenting pregnant women with singleton foetus presenting between 14 and 26 weeks.
Exclusion Criteria
•Non consenting pregnant women.
•Patients with known hypersensitivity to benzimidazole.
•Baseline haemoglobin concentration less than 7g/dl.
•Patients with multiple gestations.
•Patients with sickle cell disease
•Patients with chronic kidney disease.
•Retroviral disease patients.
•Patients that may require blood transfusion during the course of pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method